Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04779229 · ClinicalTrials.gov registry record · NA
Leveraging Evidence to Activate Parents
A NA study of Substance Use, sponsored by Oregon Social Learning Center.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT04779229: Completed NA study of Substance Use, sponsored by Oregon Social Learning Center.
NCT04779229 is a NA study of Substance Use that has completed, run by Oregon Social Learning Center. The registered enrollment target is 141 participants, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04779229, a NA study of Substance Use, has completed, sponsored by Oregon Social Learning Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
The juvenile justice (JJ) system serves over a million cases every year and represents the primary referral source for treatment of substance use and antisocial behavior in youth. However, engagement of the JJ population in treatment is alarmingly low; further, rural communities have neither access to evidence-based practices (EBPs) nor the finances and treatment infrastructure to support their delivery. However, using an innovation called task-shifting, juvenile probation/parole officers in rural communities might be able to deliver a central change mechanism for EBPs (parent activation), with the ultimate goal of improving JJ youth outcomes.
Primary Outcome
Fidelity to Parent Activation techniques by JPOs as measured using Standardized Patient Assessments (Observational coding of video recordings with trained actors).
Conditions Studied
Interventions
- BEHAVIORAL Parent Activation
- BEHAVIORAL Usual Services
Study Locations (1)
Oregon
- Oregon Social Learning Center - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2025-03-30 |
| Phase | NA |
What the finished NCT04779229 record still lists
NCT04779229 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which Parent Activation is the first listed.
NCT04779229 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT04779229 about?
NCT04779229 is a clinical study titled "Leveraging Evidence to Activate Parents". The juvenile justice (JJ) system serves over a million cases every year and represents the primary referral source for treatment of substance use and antisocial behavior in youth. However, engagement of the JJ population in treatment is alarmingly low; further, rural communities have neither access ...
What is the current status of trial NCT04779229?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2021-03-01. Estimated completion is 2025-03-30.
What conditions does trial NCT04779229 study?
This clinical trial studies the following conditions: Substance Use.
What interventions are being tested in trial NCT04779229?
The interventions under investigation include: Parent Activation (BEHAVIORAL), Usual Services (BEHAVIORAL).
Who is sponsoring clinical trial NCT04779229?
This trial is sponsored by Oregon Social Learning Center, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04779229 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04779229's enrollment target sits among peer trials
141 56th of 88 higher than 33 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI